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Abstract
Objectives. Synovitis in symptomatic knee OA (KOA) is common and is associated with joint symptoms. Optimal
synovial measurement on MRI is, however, unclear. Our aims were to examine the relationship between MRI meas-
ures of synovitis and knee symptoms in symptomatic KOA.
Methods. Data from a randomized, multicentre, placebo-controlled trial (UK-VIDEO) of vitamin-D therapy in symp-
tomatic KOA were utilized. Participants reported knee symptoms using WOMAC at baseline and annually. On
contrast-enhanced (CE) MRI, synovial thickness was measured using established, semi-quantitative methods whilst
synovial tissue volume (STV) was assessed as absolute STV (aSTV) and relative to the width of femoral condyle
(rSTV). STV of the infrapatellar region was also assessed. Associations between synovial measures and symptoms
were analysed using multiple linear regression modelling.
Results. No linear association was observed between knee symptoms and synovitis thickness scores. Whole-joint
aSTV (0.88, 95% CI: 0.17, 1.59) and infrapatellar aSTV (5.96, 95% CI: 1.22, 10.7) were positively associated with
knee pain. Whole-joint rSTV had a stronger association with pain (7.96, 95% CI: 2.60, 13.33) and total scores
(5.63, 95% CI: 0.32, 10.94). Even stronger associations were found for infrapatellar rSTV with pain (55.47, 95% CI:
19.99, 90.96), function (38.59, 95% CI: 2.1, 75.07) and total scores (41.64, 95% CI: 6.56, 76.72).
Conclusions. Whole-joint and site-specific infrapatellar STV measures on CE-MRI were associated with knee
pain, respectively. Volumes relative to the size of the femoral condyle may be promising outcome measures in
KOA trials.
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Introduction
OA of the knee is the most common cause of knee pain
among those aged 45 years and older [1] and there is
evidence to suggest that prevalence is increasing [2, 3].
Synovial inflammation is present at all stages of knee
OA (KOA) and is most likely a secondary phenomenon.
Currently, there are no licensed disease-modifying treat-
ments for knee OA with currently available interventions
aimed at alleviating painful symptoms and improving
function. The current focus is to identify clinically import-
ant tissue targets that are related to the underlying
pathogenesis of OA.
Rheumatology key messages
. Synovial tissue volume (STV) measures were strongly, and linearly, associated with knee symptoms in symptomatic KOA.
. Whole-joint absolute STV and site-specific absolute infrapatellar STV were positively associated with knee pain.
. STV measures relative to the size of the femur were strongly associated with knee symptoms.
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Synovitis has an important role in KOA [4] with data
suggesting that synovitis is an early risk factor for the
development of radiographic KOA [5–7] and rapid-onset
‘accelerated KOA’ [8]. Further, data from most observa-
tional studies, but not all, suggest that synovitis is asso-
ciated with structural progression with the evidence
suggesting that only those with severe synovitis are at
greater risk of progressing in their disease [7, 9, 10].
There is also evidence to suggest that synovitis is asso-
ciated with pain [11–14], with the degree of synovitis
correlating with the degree of knee pain in a dose-
response manner [15]. OA is widely accepted to be a
heterogeneous disease [16] thus it is likely that the se-
verity of synovitis is likely to fluctuate with symptoms.
Synovitis has been shown to resolve in a relatively short
time [11] and so has become a prominent treatment tar-
get in KOA trials. Currently, there is no consensus over
the optimum approach for the assessment of synovitis
on MRI in KOA.
There are several markers of synovitis on MRI, which
include the volume of joint effusion and increased signal
of thickened synovium on fluid sensitive sequences and,
the volume of contrast-enhanced (CE) synovial mem-
brane [17–20]. In large epidemiological imaging studies,
non-CE MRI is frequently used [10, 21, 22] though this
technique does not allow for optimum differentiation of
effusion from synovium [23]. Subsequently, CE-MRI is
the preferred method of assessment; with data from
histological studies supporting strong correlations be-
tween CE-MRI and macroscopic evaluation [23].
Furthermore, signal changes in Hoffa’s fat pad (infrapa-
tellar region) have been used as surrogate markers of
synovial activation [24]; a sensitive yet non-specific
maker of synovitis when using CE-MRI as the reference
standard [25]. Synovitis in KOA is frequently assessed
using semi-quantitative methods [22, 26, 27], in which
scores are used to grade severity of synovitis distension,
and quantitatively in which the volume of the synovial
tissue is directly measured [28].
Imaging biomarkers used to evaluate synovitis are likely
to play an increasing role in identifying participants for OA
clinical trials and assessing treatment efficacy in which
synovitis is the treatment target. Our aim was to explore
the relationship between different measures of synovitis
and symptoms in symptomatic KOA using CE-MRI.
Methods
Data source and sample size
We used cross-sectional data from the Vitamin D in OA
(UK VIDEO) trial [29] (ISRCTN94818153). VIDEO was a
3-year double-blind, randomized, placebo-controlled
trial involving five UK NHS centres, which examined the
effect of vitamin D therapy on radiographic joint space
narrowing and symptoms in men and women with
symptomatic KOA [29]. Details of the original VIDEO
study have been published previously [29]. In brief,
eligible participants had radiological evidence of KOA at
the medial tibio-femoral knee compartment [Modified
Kellgren & Lawrence (K&L) [30] score of 2–3], joint
space width >1 mm and had knee pain for most days
of the previous month. A total of 474 participants were
randomized, within centres, to receive either oral vitamin
D (800 IU/daily) or matching placebo in a 1:1 ratio.
A subsample of participants recruited at Southampton
(n¼174) had MRIs performed. Participants eligible for
this study had sagittal and/or axial T1-weighted (T1-w)
fat suppressed (FS) CE MRIs, an axial proton-density-
weighted (PD-w) FS and/or coronal short tau inversion
recovery (STIR) scan for the corresponding visit, syno-
vitis thickness scores, synovial tissue volume (STV)
measures and WOMAC symptom data at, at least, a sin-
gle visit across follow-up. Each participant contributed a
single visit to the analysis. Ethical approval was not
required for any aspect of the work presented in this
manuscript.
Magnetic resonance imaging
Images were acquired on a 1.5 T MRI scanner (Signa
(GE Healthcare)) using a dedicated phased-array knee
coil [14]. Sagittal and axial post-contrast T1-w fat sup-
pressed (FS) (repetition time (TR)¼600–800 ms, echo
time (TE)¼ 12.5–16.2 ms, acquisition matrix 256160,
slice gap¼0.6 mm, slice thickness¼ 3 mm), axial proton
density weighted (PD-w) FS (TR¼ 3800–4820 ms,
TE¼ 31.2–32.5 ms, matrix 256192, slice gap¼0.2 mm,
slice thickness¼4 mm) and coronal short tau inversion
recovery (STIR) (TR¼ 3000–4760 ms, TE¼46.1–56.9 ms,
matrix 256 192, slice gap¼0.3 mm, slice thick-
ness¼3 mm) sequences were acquired. For image ac-
quisition, participants were positioned supine for
scanning. An intravenous injection of gadodiamide
[0.2 ml/kg body weight (Omniscan, GE Healthcare)] was
administered 3 minutes prior to the acquisition of the
first CE scan [14]; with all scans acquired within
11 minutes of contrast administration.
Quantitative assessment of synovial tissue volume
A single reader (T.A.P) performed segmentation of STV
(mm3) using a semi-automated approach that has been
described previously [31]. In brief, the software segments
enhancing STV (on CE-MRI) based on a threshold, as
selected by the user, within a 3 D-mask that is applied to
the target image [31]. STV measured across the whole
joint was termed total absolute STV (aSTV). Segmentation
of STV was performed using sagittal T1-w fat suppressed
CE scans on the index (most painful) knee. Reliability of
STV assessment has been assessed previously and was
found to be excellent for both intra- (ICC3,1¼0.99) and
inter-observer agreement (ICC3,1¼0.83) [13].
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Relative measures of STV and infrapatellar synovitis
volume
The total STV in the joint compartment relative to fem-
oral condyle width was calculated and was expressed
as a single outcome; total relative STV (rSTV). To calcu-
late relative volume, we assessed the width of the fem-
oral condyle on a total of four consecutive slices (where
the femoral condyle was at its most visible and at its
greatest dimension) for each participant. All images
were maximized within the software window in order to
standardise measurements. Width measurements were
manually recorded, on a Dell monitor (1920 1080 pixel
resolution, 23-inch), for each participant in accordance
with criteria defined by Hunter et al. [27]; for the ana-
tomical delineation of the femur into trochlea and
weight-bearing regions (see Fig. 1). Width measure-
ments were averaged with total relative values calcu-
lated as follows; [total absolute STV (mm3)/mean
femoral width (mm)].
We further segmented high signals on CE-MRI in the
infrapatellar region (Fig. 1) and termed this volume total
absolute infrapatellar STV; referred throughout as infra-
patellar aSTV. The infrapatellar region was defined
as the region directly adjacent to the inferior patella
pole [27]. We further included high signals directly adja-
cent to the lateral menisci as there is evidence to sug-
gest that localized meniscal damage is associated with
surrounding synovitis [32]. Total relative infrapatellar
STV, referred to as infrapatellar rSTV, was calculated as
[total absolute infrapatellar STV (mm3)/mean femoral
width (mm)].
Semi-quantitative assessment of synovial thickness
Synovial thickness was examined in a subsample
(n¼107) of VIDEO as part of a previous study [14].
Synovial thickness was assessed using a semi-
quantitative grading system which has been previously
validated [33]. In brief, a single musculoskeletal
FIG. 1 Sagittal T1-w fat suppressed (FS) contrast-enhanced MRI of a symptomatic osteoarthritic knee
(A) Delineation of the femur for femoral condyle width measurement and (B) region of interest defined for the infrapa-
tellar (Hoffa’s) fat pad.
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radiologist with over 8 years’ experience in image as-
sessment in knee OA scored the MRIs for synovial
thickness [14]. An ordinal score of 0–3 [0¼normal,
1¼mild (<2 mm), 2¼moderate (2–4 mm) and
3¼ severe (>4 mm)] was assigned across 11 regions
including the infrapatellar region. Thickness was
assessed on either sagittal or axial post-contrast
sequences [14]. We created a composite measure of
total synovial thickness that was equal to the sum of all
synovitis scores. We then categorized total synovial
thickness as normal (0–4), mild (5–8), moderate (9–12)
and severe (13) in accordance with previous methods
[33].
Assessment of symptoms
Pain, function and stiffness symptoms were assessed
using the Western Ontario and McMaster Universities
(WOMAC) questionnaire. Each item of WOMAC was
scored on a visual analogue scale (VAS) from 0–100 mm
(0¼no pain/disability). WOMAC total was generated as a
composite of pain, function and stiffness. Scores corre-
sponded to symptoms experienced within the last 48 hrs.
Statistical methods
Characteristics of the study participants are presented
as means and standard deviations for normally distrib-
uted variables and medians and inter-quartile range
(IQR) for non-normally distributed variables. Data were
analysed using STATA (version 15.1, StataCorp.,
College Station, TX, USA). To examine the relationship
between synovitis (continuous or categoric measures)
and symptoms, we used multiple linear regression with:
(i) total aSTV; (ii) total rSTV; (iii) infrapatellar aSTV; (iv)
infrapatellar rSTV; (v) whole joint synovitis thickness
score; and (vi) infrapatellar synovitis thickness score as
the respective exposures and WOMAC symptoms (pain,
function, stiffness and total) as the outcomes. Synovitis
score was included as a categoric exposure as it was
assumed that the relationship between semi-
quantitatively assessed synovitis and knee symptoms
would be non-linear. We formally tested the assump-
tions of linear regression and confirmed that there were
no violations. All regression models were adjusted for
potential confounders which included age, sex, body
mass index (BMI) and the presence/absence of
Heberden’s nodes. We did not adjust for the allocation
of treatment intervention as it has been previously
reported that vitamin D therapy has no observed effect
on the outcomes described here [34].
Results
Subjects
In total, 96 participants had CE-MRI scans, symptom
data, synovitis thickness scores, total aSTV and total
rSTV and infrapatellar STV measured at least a single
visit across follow-up. Participants’ mean age (S.D.) was
65.4 (6 8.1) years and most participants were female.
Table 1 shows the characteristics of the included
participants.
Two participants were excluded from all analysis as
they showed evidence of high normalized residual
squared values and a high degree of leverage over the
regression models (data not shown); exclusion is in line
with current recommendations [35]. We assessed a sin-
gle visit per participant with synovitis measured at the
baseline visit in 45 (47.9%) participants, while 22
(23.4%), 23 (24.5%) and 4 (4.2%) participants had 12,
24- and 36-month follow-up visits assessed respective-
ly. WOMAC scores were captured at the time of MRI ac-
quisition in all participants. In those with missing scores
(n¼2), data at the following visit (6-months post-MRI)
was used. All participants had evidence of synovitis on
CE-MRI. In addition, whilst inclusion to the primary
VIDEO trial specified that all participants must have a
KL grade of 2–3, upon re-evaluation of the radiographs
some participants were re-graded as KL1s and KL4s.
Total absolute STV and infrapatellar STV and
symptoms
In multivariate analysis, there was a statistically signifi-
cant association between total aSTV and pain (0.88,
95% CI: 0.17, 1.59), though not with function (0.46, 95%
CI: 0.28, 1.19), stiffness (0.53, 95% CI: 0.37, 1.42)
TABLE 1 Clinical and imaging characteristics of the study
participants (n¼96)
Variable
Females, n (%) 63 (65.6)
Index knee, n (% Right) 53 (55.2)
Body mass index (BMI) (kg/m2) 28.8 (4.6)
Baseline Kellgren–Lawrence
grade (medial/lateral) in index knee
Grade 1, n (%) 19 (19.8)
Grade 2, n (%) 40 (41.6)
Grade 3, n (%) 33 (34.4)
Grade 4, n (%) 4 (4.2)
WOMACa
Pain score 33.8 (21.0)
Stiffness score 45.8 (25.3)
Function score 37.0 (22.1)
Total score 37.0 (21.1)
Presence of Heberden’s nodes,
(yes: n, %)
69 (71.9)
Total absolute STV (mm3) 9900.6 (6537.7)
Relative total STV 131.8 (86.9)
Total absolute infrapatellar STV (mm3) 2012.0 (1042.8)
Total relative infrapatellar STV 26.8 (14.0)
Results are shown as means (S.D.) or frequencies (%).
aWOMAC: Western Ontario and McMaster Universities
Osteoarthritis Index: visual analogue scale (VAS) used to
score pain, function, stiffness and total respectively from 0
to 100 units (0¼no pain / disability, 100¼high pain / dis-
ability). STV, synovial tissue volume.
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and total score (0.55, 95% CI: 0.15, 1.26); see Table 2.
Similarly, there was a statistically significant association
between infrapatellar aSTV and pain (5.96, 95% CI:
1.22, 10.7); with an increase in volume associated with
worsening knee pain (Table 2). There was, however, no
statistically significant association between infrapatellar
aSTV and function (3.31, 95% CI: 1.54, 8.17), stiffness
(2.5, 95% CI: 3.46, 8.46) and total (3.8, 95% CI:
0.88, 8.48).
Total relative STV and infrapatellar STV and
symptoms
In multivariate analysis, there was a statistically signifi-
cant association between total rSTV and knee pain
(7.96, 95% CI: 2.60, 13.33) and total score (5.63, 95%
CI: 0.32, 10.94) though there was no association with
function (4.96, 95% CI: 0.56, 10.49) and stiffness
(5.47, 95% CI: 1.29, 12.22), respectively; see Table 3.
Infrapatellar rSTV was statistically significantly associ-
ated with pain (55.47, 95% CI: 19.99, 90.96), function
(38.59, 95% CI: 2.1, 75.07) and total score (41.64, 95%
CI: 6.56, 76.72) though not with stiffness (32.61, 95%
CI: 12.45, 77.67). The reported coefficients for these
infrapatellar rSTVs appear large (e.g. the coefficient of
55.47 implies that for a 1 unit increase in infrapatellar
rSTV, this reflects a corresponding change in WOMAC
pain score of 55.47 points), though this accurately
reflects volumes that are typically small.
Total synovitis thickness scores and symptoms
In multivariate analysis, there was no statistically signifi-
cant association between severity of whole joint
TABLE 2 Association between synovitis volume and symptoms
Outcome Univariate (n 5 94) Multivariate a (n 5 94) Multivariateb (n 5 94) Multivariatec (n 5 94)
Total absolute STVd
WOMACe pain 0.89 (0.17, 1.61), 0.02 0.89 (0.17, 1.62), 0.02 0.93 (0.22, 1.64), 0.01 0.88 (0.17, 1.59), 0.02
Stiffness 0.48 (0.42, 1.38), 0.29 0.49 (0.4, 1.38), 0.28 0.53 (0.36, 1.41), 0.24 0.53 (0.37, 1.42), 0.24
Function 0.41 (0.37, 1.19), 0.3 0.41 (0.37, 1.19), 0.3 0.49 (0.24, 1.21), 0.19 0.46 (0.28, 1.19), 0.22
Total 0.52 (0.23, 1.26), 0.17 0.52 (0.22, 1.26), 0.17 0.58 (0.11, 1.28), 0.1 0.55 (0.15, 1.26), 0.12
Total absolute infrapatellar STVd
Pain 5.4 (0.63, 10.16), 0.03 5.86 (1.07, 10.65), 0.02 6.31 (1.6, 11.03), 0.01 5.96 (1.22, 10.7), 0.01
Stiffness 1.41 (4.51, 7.34), 0.64 2.15 (3.76, 8.06), 0.47 2.5 (3.38, 8.38), 0.4 2.5 (3.46, 8.46), 0.41
Function 2.09 (3.04, 7.22), 0.42 2.63 (2.52, 7.78), 0.31 3.5 (1.3, 8.31), 0.15 3.31 (1.54, 8.17), 0.18
Total 2.73 (2.16, 7.62), 0.27 3.27 (1.63, 8.16), 0.19 4.01 (0.62, 8.64), 0.09 3.8 (0.88, 8.48), 0.11
All results presented with 95% CIs and P-values. Statistically significant results (P 0.05) are shown in bold. aAdjusted for
sex. bAdjusted for sex, age, body mass index (BMI). cAdjusted for sex, age, body mass index (BMI) and presence of
Heberden’s nodes. dAbsolute effects sizes from the linear regression models reflect the change in WOMAC score for a
1 cm3 increase in volume. eWOMAC¼Western Ontario and McMaster Universities Osteoarthritis Index: visual analogue
scale (VAS) used to score knee symptoms from 0–100 (0¼no pain/disability to 100¼high pain/disability). STV, synovial tis-
sue volume.
TABLE 3 Association between relative synovitis volume and symptoms
Outcome Univariate (n 5 94) Multivariatea (n 5 94) Multivariateb (n 5 94) Multivariatec (n 5 94)
Total relative STVd
WOMACe pain 8.15 (2.7, 13.6), 0.004 8.02 (2.56, 13.48), 0.004 8.29 (2.93, 13.64), 0.003 7.96 (2.60, 13.33), 0.004
Stiffness 5.47 (1.34, 12.29), 0.11 5.19 (1.58, 11.95), 0.13 5.45 (1.24, 12.13), 0.11 5.47 (1.29, 12.22), 0.11
Function 4.84 (1.08, 10.75), 0.11 4.64 (1.27, 10.54), 0.12 5.13 (0.35, 10.61), 0.07 4.96 (0.56, 10.49), 0.08
Total 5.58 (0.03, 11.19), 0.051 5.39 (0.21, 10.99), 0.06 5.82 (0.55, 11.09), 0.03 5.63 (0.32, 10.94), 0.04
Total relative infrapatellar STVd
Pain 52.92 (16.78, 89.06), 0.005 54.26 (18.17, 90.35), 0.004 57.33 (21.84, 92.81), 0.002 55.47 (19.99, 90.96), 0.003
Stiffness 27.9 (17.5, 73.3), 0.23 30.29 (14.65, 75.23), 0.18 32.59 (12.07, 77.24), 0.15 32.61 (12.45, 77.67), 0.15
Function 31.75 (7.43, 70.93), 0.11 33.46 (5.54, 72.46), 0.09 39.53 (3.29, 75.76), 0.03 38.59 (2.1, 75.07), 0.04
Total 35.87 (1.33, 73.08), 0.06 37.56 (0.59, 74.56), 0.047 42.69 (7.82, 77.56), 0.02 41.64 (6.56, 76.72), 0.02
All results presented with 95% CIs and P-values. Statistically significant results (P 0.05) are shown in bold. aAdjusted for
sex. bAdjusted for sex, age, body mass index (BMI). cAdjusted for sex, age, body mass index (BMI) and presence of
Heberden’s nodes. dAbsolute effects sizes from the linear regression models reflect the change in WOMAC score for a
1 cm3 increase in relative volume. eWOMAC¼Western Ontario and McMaster Universities Osteoarthritis Index: visual ana-
logue scale (VAS) used to score knee symptoms from 0–100 (0¼no pain/disability to 100¼high pain/disability). STV, syn-
ovial tissue volume.
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synovitis thickness scores and symptoms (see Table 4).
In participants with mild synovial thickness, there was
no statistically significant association with pain (4.71,
95% CI: 12.29, 21.7), stiffness (1.55, 95% CI:
22.48, 19.38), function (5.64, 95% CI: 11.59, 22.86)
and total score (4.86, 95% CI: 11.77, 21.5). Further,
there was no statistically significant association between
moderate synovial thickness and pain (0.46, 95% CI:
16.14, 17.06), stiffness (4.86, 95 CI%: 15.58, 25.3),
function (6.73, 95% CI: 10.09, 23.54) and total score
(5.29, 95% CI: 10.96, 21.53). Lastly, there was no stat-
istically significant association between severe synovial
thickness and pain (9.22, 95% CI: 5.97, 24.41), stiff-
ness (7.04, 95% CI: 11.67, 25.75), function (8.04, 95%
CI: 7.35, 23.43) and total score (8.22, 95% CI: 6.65,
23.09).
Infrapatellar synovitis thickness scores and
symptoms
In a fully adjusted model, there was no statistically sig-
nificant association between mild infrapatellar synovitis
thickness and pain (2.56, 95% CI: 7.8, 12.91), stiffness
(1.39, 95% CI: 14.12, 11.34), function (3.37, 95 CI:
6.95, 13.7) and total score (2.81, 95% CI: 7.21,
12.83); see Table 5. Further, there was no statistically
significant association between moderate infrapatellar
synovitis thickness and pain (4.00, 95% CI: 14.96,
6.97), stiffness (0.43, 95% CI: 13.91, 13.05), function
(5.55, 95% CI: 16.49, 5.39) and total score (4.8,
95% CI: 15.41, 5.82). Lastly, there was no statistically
significant association between severe infrapatellar
synovitis thickness and pain (10.09, 95% CI: 15.89,
36.07), stiffness (10.58, 95% CI: 21.35, 42.52), function
(0.76, 95% CI: 26.67, 25.15) and total score (2.45,
95% CI: 22.69, 27.59).
Discussion
In this study, using CE-MRI data from a randomized trial
of symptomatic KOA, both absolute and relative meas-
ures of whole joint STV and site-specific infrapatellar
STV were associated with knee symptoms. There was
no observed association between synovial thickness
scores and knee symptoms.
Several studies have shown an association between
semi-quantitative and quantitative MRI measures of
synovitis and symptoms in symptomatic KOA though
the strength of the relationship has been shown to vary.
O’Neill and colleagues reported in a trial of intra-articular
corticosteroid injection therapy in symptomatic KOA that
synovitis volume was positively associated with increas-
ing knee pain (1.13, 95% CI: 1.87, 0.39); with a re-
duction in score indicating an increase in pain [11].
Similarly, in two separate studies using different samples
of the UK VIDEO study, synovial thickness scores (1.82,
95% CI: 0.05, 3.58) [14] and whole joint STV (b¼2.2,
95% CI: 0.6, 3.7) [13] were associated with knee pain;
with an increase in severity associated with worsening
pain. We go beyond these studies to describe the asso-
ciation between different measures of synovitis and
symptoms using CE-MRI in the same study sample,
thereby allowing for within-study comparisons.
We observed a linear association between STV (abso-
lute and relative measures) and knee pain; however, we
did not observe an association between synovitis thick-
ness (whole joint and infrapatellar) scores and symp-
toms. A possible explanation for this could be due to
differences in the structure assessed across CE-MRI
sequences. Semi-quantitative scores assess synovial
thickness which, whilst a surrogate of synovitis [23, 36],
may be inclusive of non-active inflammation with active
inflammation. In contrast, quantitative assessment of
volume captures active synovial inflammation, as distinct
from effusion, represented by signal enhancement at the
synovial membrane. Our study may also have been in-
sufficiently powered across levels of synovial thickening
to detect true associations. The observed associations
between both absolute and relative measures of STV
and multiple WOMAC subunits would, however, give
confidence that our study was suitably powered.
To our knowledge, this is the first study to have exam-
ined the cross-sectional relationship between relative
measures of STV and symptoms using CE-MRI in symp-
tomatic KOA. There is some evidence to suggest that
the size of the supra-patellar pouch is associated with
knee size [37]; thus, we hypothesized that those with a
greater bone size may have increased STV independent
of disease severity. We observed that whole-joint STV
and infrapatellar STV relative to the size of the femoral
condyle were more strongly associated with knee pain
compared with absolute measures. The method pre-
sented here for calculating relative STV and site-specific
relative infrapatellar STV could be readily applied to
similar studies of symptomatic knee OA. Future work
includes applying this method of calculating relative STV
measures to other knee OA cohorts and clinical trial
datasets; to confirm the suitability and measurement
error of this approach.
Evidence from observational studies have shown a re-
lationship between Hoffa’s synovitis and risk of radio-
graphic KOA [5, 6, 38, 39]. There is, however, little data
concerning the relationship between Hoffa’s synovitis
and pain despite evidence supporting the frequent in-
volvement of the infrapatellar region [24]. Hill et al.
showed that change in infrapatellar synovitis was asso-
ciated with change in knee pain (4.89, 95% CI: 0.42,
9.36) [10]. Similarly, we observed a relationship between
pain and infrapatellar aSTV (5.96, 95% CI: 1.22, 10.7)
and we also observed a relationship between infrapatel-
lar rSTV and pain (55.47, 95% CI: 19.99, 90.96). The
magnitude of the effect was, however, greatest when
using relative measures, suggesting that there needs to
be consideration of the heterogeneity in knee joint size
in studies of KOA and synovitis.
The main strength to this study was that the assess-
ment of synovitis was performed on CE-MRI. Although
we were unable to compare histological findings against
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MRI measures of synovitis, there is strong evidence to
support the correlations between CE-MRI assessed
synovitis and histology [23].
There are several potential limitations to our study.
Firstly, this was a secondary analysis of a randomized
trial and so the study sample reported here was relative-
ly small (n¼ 94), thereby reducing statistical power and,
therefore, our ability to detect true associations. We did,
however, observe consistent statistically significant
associations between STV and several components of
WOMAC across multivariate models, giving confidence
to our findings. Further, we measured the femoral con-
dyle width across a total of four slices. While, ideally,
femoral condyle width would be measured across all
available slices, this was not pragmatic and our meth-
ods are in agreement with previous methods used to
quantify relative values [40, 41]. Further, we measured
femoral condyle width from two points of the subchon-
dral bone, which is in keeping with previous methods
[27]. The subchondral bone is, however, subject to OA-
related structural changes including erosion and osteo-
phyte development, which may have subsequently
affected width measurements; calculating average width
measures would, however, reduce the influence of such
structures (if present) on the final calculated relative val-
ues. A further limitation is the generalisability of our
infrapatellar STV measure. There is great variability in
the definition of Hoffa’s synovitis [26, 27, 33]. We used a
modified version of BLOKS [27] to define infrapatellar
STV, which included synovitis directly adjacent to the fat
pad and within the infrapatellar region and the intercon-
dylar region extending posteriorly to the lateral menisci.
Subsequently, we were unable to differentiate origins of
inflammation; that is, inflammation having occurred in re-
sponse to infrapatellar activation or injury at the menisci.
Cartilage volume, meniscal extrusion/injury and bone mar-
row lesion (BML) volume were not captured as part of the
original protocol and so were not adjusted for in our ana-
lysis. Subsequently, while we observed a strong, statistically
significant relationship between measures of synovitis and
knee symptoms, we cannot completely exclude the contri-
bution of the other structural features to knee symptoms.
Further work is required to confirm these findings. Lastly,
due to the cross-sectional design of the study, we were un-
able to determine causality. While cross-sectional, the pre-
cision of our estimates were, however, likely improved with
the addition of data across multiple study visits.
In conclusion, we observed an association between
absolute measures of whole-joint STV and site-specific
infrapatellar STV and knee symptoms respectively in
symptomatic knee OA. Relative measures were more
strongly associated with knee symptoms and there was
no linear association between synovial thickness and
knee symptoms. Relative measures of STV may prove
useful outcomes in trials of knee OA.
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